1.Characteristics of acid reflux in Barrett's esophagus.
Junying, XU ; Jie, CHEN ; Xiaohua, HOU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2002;22(3):235-6, 264
To determine the relationship between Barrett's esophagus (BE) and features of gastroesophageal acid reflux, 24 h esophageal pH monitoring was performed in 90 patients. The patients were divided into 3 groups: 31 subjects with BE, 21 with mild esophagitis and 38 with severe esophagitis. The following parameters were evaluated: the percentage time of pH < 4; the number of reflux episodes over 5 min; the duration of longest episodes and DeMeester score over total period and the auterior three parameters in erect and supine position. All these parameters in BE were significantly different from those with mild esophagitis (P < 0.01) and not significantly different from those with severe esophagitis (P > 0.05). During supine position all the above parameters in BE were significantly different from those with reflux esophagitis (P < 0.05). It is concluded that the quantity of acid reflux is not an important factor in development of BE in gastroesophageal reflux (GER), and the acid reflux in supine position might be important in development of BE in GER.
Barrett Esophagus/etiology
;
Barrett Esophagus/*physiopathology
;
Esophagitis, Peptic/etiology
;
Gastroesophageal Reflux/*complications
;
Hydrogen-Ion Concentration
;
Supine Position
2.Analysis on the causes for refractory GERD.
Jie CHEN ; Junying XU ; Yong XU ; Xiaoping XIE ; Cuiqiong YI ; Xiaohua HOU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2002;22(1):47-49
To analyze the causes of failure in conventional treatment to refractory gastroesophageal reflux diseases (GERD) patients, 16 refractory GERD patients (group R) and 16 cases of GERD primarily diagnosed (group P) were studied. Endoscopy, pathologic examination and 14C urea breath test were conducted in every patient. 24 h ambulatory pH and bilirubin monitoring were performed with Digitrapper MK III and Synetics Bilitec 2000. It was found that esophagitis in group R was more severe than in group P. The rate of Helicobacter pylori infection in group R was significantly lower than in group P. Fraction time pH below 4.00 was not longer while the bile reflux represented by fraction time abs above 0.14 was greater for patients in the group R as compared with those in the group P. The mixed refluxes and pure bile refluxes between the two groups had significant difference. The reflux episodes in the group R mainly occurred during nights. These results indicated that severe esophagitis, especially Barrett's esophagus with complications makes it difficult to control GERD. Severe duodenogastroesophageal refluxes (DGER) are often accompanied by refractory GERD. Mixed refluxes aggravate the esophageal injuries. Pure bile refluxes and nocturnal refluxes may cause failure of administration of proton pump inhibitors (PPI) in the morning. Helicobacter pylori infection and acid refluxes may not be the direct cause of refractoriness. Individual refractory GERD patient without abnormal results on pH or bile reflux recently should be diagnosed again.
Adult
;
Barrett Esophagus
;
complications
;
Esophagitis
;
complications
;
microbiology
;
Female
;
Gastroesophageal Reflux
;
complications
;
diagnosis
;
therapy
;
Helicobacter Infections
;
complications
;
Helicobacter pylori
;
Humans
;
Male
;
Middle Aged
;
Treatment Failure
3.Analysis on the causes for refractory GERD.
Jie, CHEN ; Junying, XU ; Yong, XU ; Xiaoping, XIE ; Cuiqiong, YI ; Xiaohua, HOU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2002;22(1):47-9
To analyze the causes of failure in conventional treatment to refractory gastroesophageal reflux diseases (GERD) patients, 16 refractory GERD patients (group R) and 16 cases of GERD primarily diagnosed (group P) were studied. Endoscopy, pathologic examination and 14C urea breath test were conducted in every patient. 24 h ambulatory pH and bilirubin monitoring were performed with Digitrapper MK III and Synetics Bilitec 2000. It was found that esophagitis in group R was more severe than in group P. The rate of Helicobacter pylori infection in group R was significantly lower than in group P. Fraction time pH below 4.00 was not longer while the bile reflux represented by fraction time abs above 0.14 was greater for patients in the group R as compared with those in the group P. The mixed refluxes and pure bile refluxes between the two groups had significant difference. The reflux episodes in the group R mainly occurred during nights. These results indicated that severe esophagitis, especially Barrett's esophagus with complications makes it difficult to control GERD. Severe duodenogastroesophageal refluxes (DGER) are often accompanied by refractory GERD. Mixed refluxes aggravate the esophageal injuries. Pure bile refluxes and nocturnal refluxes may cause failure of administration of proton pump inhibitors (PPI) in the morning. Helicobacter pylori infection and acid refluxes may not be the direct cause of refractoriness. Individual refractory GERD patient without abnormal results on pH or bile reflux recently should be diagnosed again.
Barrett Esophagus/complications
;
Esophagitis/complications
;
Esophagitis/microbiology
;
Gastroesophageal Reflux/complications
;
Gastroesophageal Reflux/diagnosis
;
Gastroesophageal Reflux/*therapy
;
Helicobacter Infections/complications
;
Helicobacter pylori
;
Treatment Failure
4.Obesity and Functional Gastrointestinal Disorders.
The Korean Journal of Gastroenterology 2012;59(1):1-7
Obesity is prevalent in Korea. An increase in food intake and a decrease in energy expenditure are responsible for obesity. Gut hormones play a role in controlling food intake. Obesity is suggested to be linked to common gastrointestinal functional disorders. Obesity is associated with an increased risk of gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Epidemiologic studies indicate that obesity is associated with chronic gastrointestinal symptoms. This association suggests the possibility that obesity and functional gastrointestinal disorders may be pathophysiologically linked. However, data on the relationship between obesity and functional gastrointestinal disorders are inconsistent. In this paper, we review the role of gastrointestinal hormones in food intake and the relationship between obesity and functional gastrointestinal disorders.
Barrett Esophagus/*etiology
;
Energy Intake
;
Energy Metabolism
;
Esophageal Neoplasms/*etiology
;
Gastroesophageal Reflux/*etiology
;
Humans
;
Obesity/*complications/pathology
;
Peptide Hormones/metabolism/physiology
5.Characteristics of acid reflux in Barrett's esophagus.
Junying XU ; Jie CHEN ; Xiaohua HOU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2002;22(3):235-264
To determine the relationship between Barrett's esophagus (BE) and features of gastroesophageal acid reflux, 24 h esophageal pH monitoring was performed in 90 patients. The patients were divided into 3 groups: 31 subjects with BE, 21 with mild esophagitis and 38 with severe esophagitis. The following parameters were evaluated: the percentage time of pH < 4; the number of reflux episodes over 5 min; the duration of longest episodes and DeMeester score over total period and the auterior three parameters in erect and supine position. All these parameters in BE were significantly different from those with mild esophagitis (P < 0.01) and not significantly different from those with severe esophagitis (P > 0.05). During supine position all the above parameters in BE were significantly different from those with reflux esophagitis (P < 0.05). It is concluded that the quantity of acid reflux is not an important factor in development of BE in gastroesophageal reflux (GER), and the acid reflux in supine position might be important in development of BE in GER.
Adult
;
Barrett Esophagus
;
etiology
;
physiopathology
;
Esophagitis, Peptic
;
etiology
;
Female
;
Gastroesophageal Reflux
;
complications
;
Humans
;
Hydrogen-Ion Concentration
;
Male
;
Middle Aged
;
Supine Position
6.The Prevalence of Barrett's Esophagus and the Comparison of Barrett's Esophagus with Cardiac Intestinal Metaplasia in the Health Screening at a Secondary Care Hospital.
Cheul Young CHOI ; Seungchul SUH ; Jae Serk PARK ; Hyun Jeong LEE ; Jong Sup LEE ; Hyo Sun CHOI ; Hyun Sung PARK ; Seung Goun HONG
The Korean Journal of Gastroenterology 2012;60(4):219-223
BACKGROUND/AIMS: The purpose of this study was to estimate the prevalence of Barrett's esophagus (BE) and its association with reflux esophagitis (RE) and peptic ulcer disease detected by free charge endoscopy which was covered by the National Health Insurance at a secondary care hospital, and to compare the results of the biopsy of BE with that of cardiac intestinal metaplasia (CIM). METHODS: A total of 4,002 patients underwent endoscopy from March 2010 to December 2012. BE was diagnosed if there was histologically proven specialized intestinal metaplasia, and CIM was diagnosed if intestinal metaplasia was accompanied with chronic gastritis. RESULTS: Four hundred twenty four patients underwent endoscopic biopsy, and the prevalence of BE was 1.0% (42/4,002). The mean age and the proportion of males in BE were significantly higher than those of the rest of study population, and BE had slight tendency related to RE than the rest of study population. CIM was observed in 34 patients and BE and CIM showed similar results, regarding age, sex and association with RE. The mean length of endoscopic Barrett's mucosa of BE group was 9.2+/-5.1 mm, and it was similar to that of CIM. CONCLUSIONS: The prevalence of BE in the secondary care hospital was not low, and old age and male sex were significantly associated with BE. Because BE was observed in about 10% of biopsied patients and CIM was observed in a similar percentage with BE, the precise targeted biopsy is warranted and the biopsy method should be reestablished through the large prospective study of multiple secondary care hospitals.
Adult
;
Aged
;
Aged, 80 and over
;
Barrett Esophagus/complications/epidemiology/*pathology
;
Duodenal Ulcer/complications/epidemiology/pathology
;
Esophagoscopy
;
Female
;
Gastroesophageal Reflux/complications/epidemiology/pathology
;
Hospitals
;
Humans
;
Male
;
Metaplasia/complications/epidemiology/*pathology
;
Middle Aged
;
Prevalence
;
Secondary Care
;
Stomach Ulcer/complications/epidemiology/pathology
7.Immunohistochemical Expression of the p53 and Ki-67 Proteins in Barrett's Esophagus in Korea.
Chang Whan KIM ; Bo In LEE ; Beung Wook KIM ; Jin Il KIM ; Soo Heon PARK ; Jae Kwang KIM ; Sok Won HAN ; In Sik JUNG ; Hee Sik SUN ; A Won LEE ; Kyo Young LEE
The Korean Journal of Gastroenterology 2005;46(3):189-195
BACKGROUND/AIMS: Barrett's esophagus is a premalignant lesion of the esophagus in which normal squamous epithelium is replaced by intestinalized columnar epithelium. In Korea, adenocarcinoma associated with Barrett's esophagus is rare compared with that of Western country. The purpose of this study was to investigate the immunohistochemical expression of p53 and Ki-67 in Barrett's esophagus which had predictive value for cancer risk in Korea. METHODS: Ninety five patients (43 male and 52 female, median age 44, range 21-75) who have been suspected to have Barrett's esophagus by endoscopic assessment were enrolled in this study. Alcian blue (pH 2.5) and high ion diamine stain for the evaluation of specialized intestinal metaplasia (SIM) and immunohistochemical stain for p53 and Ki-67 were done. RESULTS: 57.9% (55/95) of biopsies from the columnar lined esophagus showed SIM, but no dyspalsia. 56.4% (31/55) of Barrett's esophagus showed sulfomucin positive colonic metaplasia. The p53 expression was observed in 10.9% (6/55) of the patients of Barrett's esophagus and all of them showed colonic metaplasia. Ki-67 labeling index showed no difference significantly. CONCLUSIONS: In Korea, 10.9% of Barrett's esophagus had p53 mutation and moreover all of them had colonic metaplasia. Consequently, we expect that these patients have high risk of developing dysplasia and adenocarcinoma and need careful follow-up.
Adenocarcinoma/etiology/genetics
;
Adult
;
Aged
;
Barrett Esophagus/complications/*metabolism
;
Esophageal Neoplasms/etiology/genetics
;
Female
;
Humans
;
Immunohistochemistry
;
Ki-67 Antigen/*metabolism
;
Male
;
Middle Aged
;
Risk Factors
;
Tumor Suppressor Protein p53/*metabolism
8.Clinical Characteristics of Gastroesophageal Reflux Diseases and Association with Helicobacter pylori Infection.
Byung Chang KIM ; Young Hoon YOON ; Hyun Soo JYUNG ; Jae Bock CHUNG ; Chae Yun CHON ; Sang In LEE ; Yong Chan LEE
The Korean Journal of Gastroenterology 2006;47(5):363-369
BACKGROUND/AIMS: The prevalence of gastroesophageal reflux disease (GERD) in Korea was believed to be low until now. Korea is now believed to be on the evolving stage of GERD in its' prevalence. The aims of this study were to evaluate the epidemiologic and clinicopathologic characteristics among the subgroups of GERD i.e. non-erosive GERD (NERD), erosive GERD (ERD) and Barrett's esophagus (BE), and the role of Helicobacter pylori (H. pylori) infection in the pathogenesis of GERD. METHODS: A total of 253 patients with typical symptoms of GERD who underwent EGD were enrolled from October 2002 to January 2004. Patients were grouped as NERD, ERD or BE based on the symptoms and endoscopic findings. BE was histologically confirmed if necessary. Various clinical parameters including the status of H. pylori infection were analyzed. RESULTS: Among 253 patients, 106 patients were classified as NERD while 116 and 31 patients were classified as ERD and BE group respectively. BE and ERD group showed no gender predilection while NERD showed female preponderance (2.31:1, p<0.05). NERD group were younger (49.57 y.o.) than BE (57.87 y.o.) and ERD (52.30 y.o.) group. About three quarters of the patients of erosive esophagitis were LA-A (74.2%) grade. This suggests the mild nature of erosive esophagitis in Korea. ERD showed significantly higher BMI (kg/m2) compared to NERD (p<0.05). Hiatal hernia was frequently associated with BE and ERD (p<0.05), but less frequently in NERD. Overall H. pylori positivity among GERD was significantly lower than the age and gender matched control group (p<0.05). CONCLUSIONS: Subgroups of GERD in Korea showed different epidemiologic and clinical characteristics. Lower rate of H. pylori infection among GERD group may reflect the protective role of H. pylori infection regarding GERD prevalence in Korea.
Aged
;
Barrett Esophagus/diagnosis/drug therapy/microbiology
;
Female
;
Gastroesophageal Reflux/diagnosis/drug therapy/*microbiology
;
Helicobacter Infections/*complications/drug therapy/epidemiology
;
*Helicobacter pylori
;
Humans
;
Korea/epidemiology
;
Male
;
Middle Aged
;
Prevalence
9.Barrett's Esophagus and Cancer Risk: How Research Advances Can Impact Clinical Practice.
Massimiliano DI PIETRO ; Durayd ALZOUBAIDI ; Rebecca C FITZGERALD
Gut and Liver 2014;8(4):356-370
Barrett's esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), whose incidence has increased sharply in the last 4 decades. The annual conversion rate of BE to cancer is significant, but small. The identification of patients at a higher risk of cancer therefore poses a clinical conundrum. Currently, endoscopic surveillance is recommended in BE patients, with the aim of diagnosing either dysplasia or cancer at early stages, both of which are curable with minimally invasive endoscopic techniques. There is a large variation in clinical practice for endoscopic surveillance, and dysplasia as a marker of increased risk is affected by sampling error and high interobserver variability. Screening programs have not yet been formally accepted, mainly due to the economic burden that would be generated by upper gastrointestinal endoscopy. Screening programs have not yet been formally accepted, mainly due to the economic burden that would be generated by widespread indication to upper gastrointestinal endoscopy. In fact, it is currently difficult to formulate an accurate algorithm to confidently target the population at risk, based on the known clinical risk factors for BE and EAC. This review will focus on the clinical and molecular factors that are involved in the development of BE and its conversion to cancer and on how increased knowledge in these areas can improve the clinical management of the disease.
Adenocarcinoma/*etiology
;
Animals
;
Barrett Esophagus/*complications/diagnosis
;
Diagnostic Imaging/methods
;
Disease Models, Animal
;
Epigenesis, Genetic/physiology
;
Esophageal Neoplasms/diagnosis/*etiology
;
Esophagoscopy/methods
;
Forecasting
;
Genetic Markers/physiology
;
Humans
;
Mice
;
Practice Guidelines as Topic
;
Risk Factors
10.Updated Guidelines 2012 for Gastroesophageal Reflux Disease.
Hye Kyung JUNG ; Su Jin HONG ; Yunju JO ; Seong Woo JEON ; Yu Kyung CHO ; Kwang Jae LEE ; Joon Seong LEE ; Hyo Jin PARK ; Ein Soon SHIN ; Sun Hee LEE ; Sang Uk HAN
The Korean Journal of Gastroenterology 2012;60(4):195-218
In 2010, a Korean guideline for the management of gastroesophageal reflux disease (GERD) was made by the Korean Society of Neurogastroenterology and Motility, in which the definition and diagnosis of GERD were not included. The aim of this guideline was to update the clinical approach to the diagnosis and management of GERD in adult patients. This guideline was developed by the adaptation process of the ADAPTE framework. Twelve guidelines were retrieved from initial queries through the Appraisal of Guidelines for Research & Evaluation II process. Twenty-seven statements were made as a draft and revised by modified Delphi method. Finally, 24 consensus statements for the definition (n=4), diagnosis (n=7) and management (n=13) of GERD were developed. Multidisciplinary experts participated in the development of the guideline, and the external review of the guideline was conducted at the finalization phase.
Antacids/therapeutic use
;
Anti-Ulcer Agents/therapeutic use
;
Antidepressive Agents/therapeutic use
;
Barrett Esophagus/complications/diagnosis
;
Databases, Factual
;
Diet
;
Dose-Response Relationship, Drug
;
Drug Administration Schedule
;
Drug Therapy, Combination
;
Endoscopy, Digestive System
;
Esophageal pH Monitoring
;
Gastroesophageal Reflux/complications/*diagnosis/drug therapy
;
Histamine Antagonists/therapeutic use
;
Humans
;
Peptic Ulcer/complications/diagnosis
;
Proton Pump Inhibitors/therapeutic use
;
Stomach Neoplasms/complications/diagnosis